News
CivicaScript®, LLC, a nonprofit company dedicated to bringing low-cost generic medicines to U.S. patients, today announced the availability of its generic capecitabine. Capecitabine is a nucleoside ...
Chemoradiation combined with immunotherapy significantly boosts survival in patients with resected extrahepatic ...
13d
MedPage Today on MSNCombo Therapy Boosts Survival in Resectable Biliary Tract CancerCamrelizumab, an investigational immunotherapy, on top of adjuvant capecitabine (Xeloda) and radiotherapy, improved survival outcomes in patients with resectable biliary tract cancers (extrahepatic ...
Transcriptomic Predictors of Survival for Palbociclib + Endocrine Therapy Versus Capecitabine in Aromatase Inhibitor–Resistant Breast Cancer From the GEICAM/2013-02 PEARL Trial.
Adjuvant chemoradiation combined with camrelizumab was well tolerated and yielded significantly improved long-term survival,” the researchers wrote.
8d
TipRanks on MSNJazz Pharmaceuticals’ Zanidatamab Study: A Potential Game-Changer in Breast Cancer Treatment?Jazz Pharmaceuticals (($JAZZ)) announced an update on their ongoing clinical study. The clinical study titled A Phase 3, Randomized, Open-label, ...
Research shows that patients with six or more prescriptions for gabapentin, commonly used to treat lower back pain, were 29% more likely to be diagnosed with dementia and 85% more likely to be ...
Further data could back zanidatamab as advanced treatment for HER2-positive advanced gastroesophageal adenocarcinoma.
The findings of this case series study show substantial variation in the choice of the TNT regimen and were overall aligned with those reported in clinical trials, suggesting the efficacy of TNT in a ...
Bispecific antibodies (bsAbs) have emerged as a novel class of therapeutics, offering a dual-targeting strategy to enhance the therapeutic efficacy of monoclonal antibodies, which is often limited by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results